Depression and Anxiety in Parkinson's Disease: Possible Effect of Genetic Variation in the Serotonin Transporter

Journal of Geriatric Psychiatry and Neurology - Tập 12 Số 2 - Trang 49-52 - 1999
Matthew Menza1, Brandon Palermo, Rocco DiPaola, Jacob I. Sage, Michael Ricketts
1Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA.

Tóm tắt

Recently, a functional polymorphism in the promoter region of the serotonin transporter gene has been linked to anxiety. In cell culture, the short allele of this polymorphism synthesizes less serotonin transporter, resulting in a reduction of the removal of serotonin from the synaptic cleft. This pilot study examines depression and anxiety in Parkinson's disease patients as a function of the variation in this polymorphism. Thirty-two patients were geno typed and then blindly administered the Hamilton Depression and Anxiety Scales. Clinical data on the neurologic features of the disease were also gathered. Patients with the short allele of the serotonin transporter promotor scored significantly higher on both the depression and anxiety measures. There were no differences between groups for any neurologic variable. Patients with the short allele were more likely to have scores for anxiety and depres sion that indicated "caseness." This study suggests that the short allele of the serotonin transporter gene may represent a significant risk factor for the development of anxiety and depression in Parkinson's disease patients. (J Geriatr Psychiatry Neurol 1999; 12:49-52).

Từ khóa


Tài liệu tham khảo

10.1176/ajp.149.4.443

10.1016/0006-3223(93)90237-8

10.1176/ajp.143.6.756

10.1007/BF00314109

10.1176/ajp.151.11.1605

10.1007/BF02327574

10.1126/science.8209254

10.1097/00041444-199800820-00001

10.1016/0169-328X(93)90069-2

10.1046/j.1471-4159.1996.66062621.x

10.1126/science.274.5292.1527

Collier DA, 1996, Mol Psychiatry, 1, 453

10.1097/00001756-199703240-00048

10.1038/sj.mp.4000275

Fahn S., Elton RL The UPDRS Development Committee. Recent developments in Parkinson's disease . Vol 2. Florham Park, NJ: MacMillan, 1987:153-163.

10.1111/j.1532-5415.1982.tb02835.x

10.1111/j.2044-8260.1967.tb00530.x

10.1111/j.2044-8341.1959.tb00467.x

Folstein MF, 1975, Psychiatry Res, 12, 189, 10.1016/0022-3956(75)90026-6

SAS Institute Inc., 1988, SAS procedure guide for personal computers, 6

10.1016/0888-7543(92)90398-C

10.1126/science.274.5292.1483

10.1002/syn.890170102

10.1016/0163-7258(95)98597-J

10.1016/0163-7258(95)00004-Z

10.1093/clinchem/40.2.288

10.1192/bjp.142.2.188

10.1001/archpsyc.1987.01800180093014

Khan A. Neurochemistry of schizophrenia and depression. Clovis, CA: A.J. Publisher, 1998 :225-235.

McGeer PL, 1976, J Neurochem, 26, 65, 10.1111/j.1471-4159.1976.tb04437.x

10.1016/0197-4580(95)02005-5

10.1016/S0079-6123(08)64585-9

10.1016/S0006-3223(96)00215-6